TERAWULF INC. WULF

NASDAQ Price as of Nov 6, 2026 · Fiscal year ended Dec 31, 2025 · Latest quarter Sep 30, 2026

$11.35
$9.51
$29.84
Market cap
$5.69B
P/E (GAAP, TTM)
—
P/E (operating)
—
Dividend yield
0.0%
Revenue growth YoY
50.7%
EPS growth YoY
97.3%
ROIC
—
Piotroski F-score
1

Three ways to read the P/E

P/E (GAAP, TTM)
—

Net income of the last 4 quarters. Includes investment gains and one-time items.

P/E (GAAP, annual)
—

Net income of the latest fiscal year. Includes investment gains and one-time items.

P/E (operating)
—

After-tax operating income only: the core business.

P/E (excl. gains)
—

Net income after removing identified investment and asset-sale gains.

How it has changed

Values as they were known at each quarter-end. Green = moved in the better direction, red = worse.

Metric 2026Q3 2026Q2Change QoQ Year agoChange YoY
Revenue growth YoY (qtr) -6.0% -1.1%-4.9 pts ——
EPS growth YoY (qtr) -3,780.0% -531.3%-3,248.8 pts ——
Revenue growth (TTM) 14.6% —— ——
EPS growth (TTM) -1,122.2% —— ——
P/E (GAAP, TTM) — —— ——
P/E (operating) — —— ——
P/E (excl. gains) — —— ——
P/B 41.87 69.87-28.00 ——
ROIC — —— ——
Net margin -392.6% -392.6%0.0 pts ——
Dividend yield 0.0% 0.0%0.0 pts ——
EPS (TTM) -4.40 —— ——
Price $14.79 $24.68-40.1% ——

History by quarter-end

Reported quarters

Quarter endedRevenueQoQYoY EPSQoQYoYNet margin
Sep 30, 2026 $76.23M 70.3% 50.7% -0.03 98.5% 97.3% 931.3%
Jun 30, 2026 $44.77M 31.6% -6.0% -1.94 -92.1% -3,780.0% -2,099.6%
Mar 31, 2026 $34.01M -5.1% -1.1% -1.01 -215.6% -531.3% -1,257.3%
Dec 31, 2025 * $35.84M -29.1% 2.4% -0.32 71.7% -255.6% -353.2%
Sep 30, 2025 $50.58M 6.2% 86.9% -1.13 -2,160.0% -1,783.3% -899.7%
Jun 30, 2025 $47.64M 38.5% 33.9% -0.05 68.8% -66.7% -38.6%
Mar 31, 2025 $34.41M -1.7% -18.9% -0.16 -77.8% -433.3% -178.5%
Dec 31, 2024 * $34.99M 29.3% 50.2% -0.09 -50.0% -350.0% -83.5%
Sep 30, 2024 $27.06M -23.9% 42.8% -0.06 -100.0% 33.3% -84.0%
Jun 30, 2024 $35.57M -16.2% 130.2% -0.03 0.0% 62.5% -30.6%
Mar 31, 2024 $42.43M 82.2% 267.9% -0.03 -50.0% 81.3% -22.7%
Dec 31, 2023 * $23.29M 22.8% 143.4% -0.02 77.8% 88.9% -45.2%

* Q4 is not filed separately. It is calculated as the fiscal year minus the first three quarters.

All figures

Price & size
Fiscal year end Dec 31, 2025 End date of the latest annual (10-K) report used.
Price date Nov 6, 2026 Date of the latest closing price used.
Price $11.35 Latest closing price.
Market cap $5.69B Price × shares outstanding.
Enterprise value $5.52B Market cap + debt − cash: the price of the whole business.
Shares 501.52M Shares outstanding used for market cap.
Valuation
P/E (GAAP, annual) — Price ÷ diluted earnings per share of the latest fiscal year. Uses NET income, so it includes investment gains and one-time items. Blank when earnings are negative.
P/E (GAAP, TTM) — Price ÷ the sum of the last four quarters of diluted EPS. Like P/E but more current. Includes investment gains and one-time items.
P/E (operating) — Market cap ÷ after-tax OPERATING income (latest fiscal year). Core business only: leaves out interest, investment gains and one-time items.
P/E (operating, TTM) — Market cap ÷ after-tax operating income of the last four quarters.
P/E (excl. gains) — Market cap ÷ net income after removing identified investment and asset-sale gains (after tax). Equals the GAAP P/E when no gains were identified.
PEG — P/E ÷ 3-year EPS growth rate (in %). Below 1 can mean growth is cheap.
PEG (TTM) — TTM P/E ÷ TTM EPS growth rate (in %).
Earnings yield -11.6% Net income ÷ market cap. The inverse of the P/E.
Earnings yield (TTM) -29.1% TTM EPS ÷ price.
P/B 40.53 Market cap ÷ shareholders' equity. Blank when equity is negative.
P/S 33.79 Market cap ÷ revenue of the latest fiscal year.
P/S (TTM) 29.83 Market cap ÷ revenue of the last four quarters.
P/FCF — Market cap ÷ free cash flow (operating cash flow − capital spending). Blank when FCF is negative.
EV/EBITDA — Enterprise value ÷ EBITDA. Useful for comparing companies with different debt levels.
EV/EBIT — Enterprise value ÷ operating income.
EV/Sales 32.79 Enterprise value ÷ revenue.
Book value / share 0.28 Shareholders' equity ÷ shares.
FCF yield -20.8% Free cash flow ÷ market cap.
Operating vs. one-time earnings
Operating EPS -0.29 After-tax operating income per share (latest fiscal year).
Investment gains $0 Gains (+) or losses (−) on investments inside net income, when the company reported them with the standard tags. Blank = none identified.
Asset-sale gains -$4.90M One-time gains or losses from selling property, assets or businesses. Blank = none identified.
Non-operating income -$475.13M Pre-tax income minus operating income: interest, investment results and one-time items combined.
Gains as % of net income -0.6% Identified investment and asset-sale gains (after tax) as a share of net income. A high value means reported earnings are flattered by non-core gains.
Latest quarter & trailing 12 months
Latest quarter Sep 30, 2026 End date of the most recent reported quarter.
Revenue (qtr) $76.23M Revenue of the latest reported quarter.
Net income (qtr) $709.91M Net income of the latest reported quarter.
EPS (qtr) -0.03 Diluted EPS of the latest reported quarter.
Revenue growth YoY (qtr) 50.7% Latest quarter revenue vs the same quarter a year earlier.
Revenue growth QoQ (qtr) 70.3% Latest quarter revenue vs the previous quarter.
EPS growth YoY (qtr) 97.3% Latest quarter EPS vs the same quarter a year earlier.
EPS growth QoQ (qtr) 98.5% Latest quarter EPS vs the previous quarter.
Net income growth YoY (qtr) 256.0% Latest quarter net income vs the same quarter a year earlier.
Net income growth QoQ (qtr) 175.5% Latest quarter net income vs the previous quarter.
Gross margin (qtr) 15.2% Gross profit ÷ revenue in the latest quarter.
Operating margin (qtr) -115.7% Operating income ÷ revenue in the latest quarter.
Net margin (qtr) 931.3% Net income ÷ revenue in the latest quarter.
Revenue (TTM) $190.85M Revenue of the last four quarters.
Net income (TTM) -$784.22M Net income of the last four quarters.
EPS (TTM) -3.30 Sum of the last four quarters of diluted EPS.
Revenue growth (TTM) 13.9% Last four quarters of revenue vs the four quarters before.
EPS growth (TTM) -130.8% Last four quarters of EPS vs the four quarters before.
Net income growth (TTM) -39.0% Last four quarters of net income vs the four quarters before.
Dividends & shareholder returns
Dividend yield 0.0% Dividends paid per share over the last 12 months ÷ price.
Dividend / share (TTM) — Dividends per share paid over the last 12 months.
Payout ratio — Dividends per share ÷ EPS. Above 100% means the dividend exceeds earnings.
FCF payout ratio — Dividends ÷ free cash flow.
Dividend growth (1y) — Dividends per share vs the same 12-month window a year earlier.
Dividend CAGR (3y) — Annualised dividend growth over 3 years.
Dividend CAGR (5y) — Annualised dividend growth over 5 years.
Payments (12m) — Number of dividend payments in the last 12 months.
Last ex-dividend date Dec 14, 2021 Most recent ex-dividend date.
Buyback yield 0.6% Share repurchases ÷ market cap.
Shareholder yield 0.6% Dividend yield + buyback yield.
Profitability
Gross margin 39.2% Gross profit ÷ revenue (latest fiscal year).
EBITDA margin -110.5% EBITDA ÷ revenue.
Operating margin -110.5% Operating income ÷ revenue.
Net margin -392.6% Net income ÷ revenue.
FCF margin -702.5% Free cash flow ÷ revenue.
ROE -470.9% Return on equity: net income ÷ shareholders' equity. Blank when equity is negative.
ROA -10.1% Return on assets: net income ÷ total assets.
ROIC — Return on invested capital: after-tax operating income ÷ (equity + debt − cash).
Growth (annual)
Revenue growth (annual) 20.3% Latest fiscal year revenue vs the year before.
Net income growth (annual) -813.3% Latest fiscal year net income vs the year before.
EPS growth (annual) -690.5% Latest fiscal year diluted EPS vs the year before.
Revenue CAGR (3y) 123.8% Annualised revenue growth over 3 fiscal years.
EPS CAGR (3y) — Annualised EPS growth over 3 fiscal years.
Financial health
Current ratio 2.00 Current assets ÷ current liabilities. Above 1 means short-term bills are covered.
Quick ratio 2.00 (Current assets − inventory) ÷ current liabilities.
Cash ratio 1.88 Cash ÷ current liabilities.
Debt / equity 22.06 Total debt ÷ shareholders' equity. Blank when equity is negative.
Debt / assets 0.47 Total debt ÷ total assets.
Debt / EBITDA — Total debt ÷ EBITDA: roughly how many years of earnings it takes to repay debt.
Net debt / EBITDA — (Debt − cash) ÷ EBITDA. Negative means more cash than debt.
Interest coverage -2.32 Operating income ÷ interest expense.
Earnings quality
FCF conversion — Free cash flow ÷ net income. Above 100% means profits turn into real cash.
Accruals ratio -8.2% (Net income − operating cash flow) ÷ assets. High values can signal low-quality earnings.
Stock comp % revenue 30.2% Share-based compensation ÷ revenue.
R&D % revenue — Research & development spending ÷ revenue.
SG&A % revenue — Selling, general & administrative expense ÷ revenue.
Tax rate used 21.0% Effective tax rate used for after-tax figures (capped 0–35%; 21% when unknown).
Efficiency
Asset turnover 0.03 Revenue ÷ total assets.
Days sales outstanding 3 Average days to collect payment from customers.
Days inventory — Average days inventory is held.
Days payables 288 Average days to pay suppliers.
Trading & momentum
52-week high $29.84 Highest price in the last 52 weeks.
52-week low $9.51 Lowest price in the last 52 weeks.
From 52-week high -62.0% How far below the 52-week high the price is (0% = at the high).
Above 52-week low 19.3% How far above the 52-week low the price is.
Avg volume (30d) 45.04M Average shares traded per day over the last 30 days.
Avg $ volume (30d) $539.63M Average dollars traded per day over the last 30 days: a liquidity measure.
Scores
Piotroski F-score 1 Nine yes/no tests of profitability, leverage and efficiency. 8–9 is strong, 0–2 is weak. Missing data counts as a fail.
Altman Z-score 0.57 Bankruptcy-risk score. Above 2.99 is safe, below 1.81 is distress. Not meaningful for banks and insurers.
Reported figures (latest fiscal year)
Revenue $168.46M Revenue of the latest fiscal year.
Net income -$661.42M Net income of the latest fiscal year.
Diluted EPS -1.66 Diluted earnings per share of the latest fiscal year.
EBITDA -$186.21M Operating income + depreciation & amortization.
Free cash flow -$1.18B Operating cash flow − capital spending.
Total debt $3.10B Long-term plus current debt.
Cash $3.27B Cash and equivalents.
Equity $140.45M Shareholders' equity.
Total assets $6.56B Total assets.